VCM
CLPT icon

Versant Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Versant Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.7K Buy
3,458
+3,397
+5,569% +$42.4K 0.01% 1217
2026
Q1 		$555 Buy
+61
New +$770 ﹤0.01% 2718

Other funds holding CLPT

PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
LWM
Lodestone Wealth Management Spokane, Washington $283M AUM 33.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
CSB
City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return
FMP
Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Versant Capital Management's CLPT Position: Q2 2026 in Review

Versant Capital Management increased its ClearPoint Neuro (CLPT) stake by 5,569% in Q2 2026, buying an estimated $42.4K and bringing the position to 3,458 shares worth $61.7K. The position accounts for 0.01% of the portfolio, ranked #1217.

Versant Capital Management first reported a position in CLPT in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Versant Capital Management held 3,458 shares of ClearPoint Neuro worth $61.7K as of Q2 2026.
  • Versant Capital Management bought 3,397 ClearPoint Neuro shares in Q2 2026, an estimated $42.4K.
  • ClearPoint Neuro made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1217 holding.
  • Versant Capital Management first reported a position in ClearPoint Neuro in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.